597 related articles for article (PubMed ID: 31696945)
1. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696945
[TBL] [Abstract][Full Text] [Related]
2. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006401. PubMed ID: 28685504
[TBL] [Abstract][Full Text] [Related]
3. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E
Cochrane Database Syst Rev; 2014 Jul; (7):CD006401. PubMed ID: 25054950
[TBL] [Abstract][Full Text] [Related]
4. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Strandberg T; Tonstad S; Gylling H
Cochrane Database Syst Rev; 2010 Jul; (7):CD006401. PubMed ID: 20614444
[TBL] [Abstract][Full Text] [Related]
5. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
7. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
Luirink IK; Wiegman A; Kusters DM; Hof MH; Groothoff JW; de Groot E; Kastelein JJP; Hutten BA
N Engl J Med; 2019 Oct; 381(16):1547-1556. PubMed ID: 31618540
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
Wiegman A; Hutten BA; de Groot E; Rodenburg J; Bakker HD; Büller HR; Sijbrands EJ; Kastelein JJ
JAMA; 2004 Jul; 292(3):331-7. PubMed ID: 15265847
[TBL] [Abstract][Full Text] [Related]
9. [Treatment with statins in children with familial hypercholesterolemia].
Kamińska E; Hennig M; Brandt A; Bautembach Minkowska J; Myśliwiec M
Dev Period Med; 2016; 20(4):328-334. PubMed ID: 28216488
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
11. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL
JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
[TBL] [Abstract][Full Text] [Related]
13. Familial hypercholesterolemia in children.
Rodenburg J; Vissers MN; Wiegman A; Trip MD; Bakker HD; Kastelein JJ
Curr Opin Lipidol; 2004 Aug; 15(4):405-11. PubMed ID: 15243213
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
McCullough PA; Ballantyne CM; Sanganalmath SK; Langslet G; Baum SJ; Shah PK; Koren A; Mandel J; Davidson MH
Am J Cardiol; 2018 Apr; 121(8):940-948. PubMed ID: 29472008
[TBL] [Abstract][Full Text] [Related]
17. When do paediatric patients with familial hypercholesterolemia need statin therapy?
Hennig M; Brandt A; Bautembach-Minkowska J; Świętoń D; Mickiewicz A; Chmara M; Wasąg B; Kamińska E; Balcerska A; Limon J; Rynkiewicz A; Gruchała M; Myśliwiec M
Dev Period Med; 2017; 21(1):43-50. PubMed ID: 28551692
[TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering agents for nephrotic syndrome.
Kong X; Yuan H; Fan J; Li Z; Wu T; Jiang L
Cochrane Database Syst Rev; 2013 Dec; (12):CD005425. PubMed ID: 24327265
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
